Lobbying client · LD-2 disclosures
Amyris Biotechnologies Inc
California
8 filings from 2 registrants · 2008–2009 · latest filed Apr 20, 2009
Reported on its behalf
$320K
every LD-2 on file
Its own filed spend
$220K
lobbying for itself
Fees to outside firms
$100K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Energy/Nuclear
ENG
4 filings
$190K on those filings
Agriculture
AGR
3 filings
$130K on those filings
Fuel/Gas/Oil
FUE
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Adrienne Alvord Amyris Biotechnologies, Inc.4 filingsthrough 2008
- Kara D'Onofrio Byler Liebman & Associates, Inc.3 filingsthrough 2009
- Murray Liebman Liebman & Associates, Inc.3 filingsthrough 2009
- Deborah Cox Liebman & Associates, Inc.2 filingsthrough 2009
- Michael Mcadams Amyris Biotechnologies, Inc.2 filingsthrough 2008
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: amyris-biotechnologies-inc.